Tsutomu Narikiyo

Director/Board Member at UNIGEN Inc.

64 year

Health Technology

Consumer Services

Producer Manufacturing

Profile

Tsutomu Narikiyo is currently a Director at UNIGEN Inc. He previously worked as an Outside Director at UMN Pharma, Inc. and as a Deputy Manager-New Business Promotions at IHI Corp.
Narikiyo received his undergraduate degree from Seikei University in 1982.

Tsutomu Narikiyo active positions

Companies	Position	Start
UNIGEN Inc. UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan.	Director/Board Member	01/06/2010

All active positions of Tsutomu Narikiyo

Former positions of Tsutomu Narikiyo

Companies	Position	End
IHI CORPORATION	Corporate Officer/Principal	-
UMN PHARMA INC.	Director/Board Member	-

See the detail of Tsutomu Narikiyo's experience

Training of Tsutomu Narikiyo

Seikei University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tsutomu Narikiyo's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
IHI CORPORATION	Producer Manufacturing

Private companies	2
UMN Pharma, Inc. UMN Pharma, Inc. Pharmaceuticals: MajorHealth Technology UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It operates through a following business division: Next-generation biopharmaceutical in-house development business and Biopharmaceutical contract manufacturing business. The Next-generation biopharmaceutical in-house development business engages in the research and development of next-generation logical vaccine by integrating next-generation biopharmaceutical drug substance manufacturing technology, adjuvant technology and drug delivery technology. The Biopharmaceutical contract manufacturing business offers study samples, investigational drugs, products, and various evaluation test results. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan.	Health Technology
UNIGEN Inc. UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan.	Health Technology